Cancer Immunotherapy, LYMPHIR, launched in the U.S. in December 2025 Completed $36 million in strategic financings, of which $18 million was via private placement and ...

University of Hawaiʻi Cancer Center researchers found in laboratory and animal models that when breast cancers stop ...

“These findings by our University of Hawai‘i Cancer Center research team show that drug resistance is not necessarily the end ...

For patients living with HER2-positive metastatic breast cancer, the recent FDA approval of trastuzumab deruxtecan (brand ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), a common but overlooked virus that poses serious risks to vulnerable ...

Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...

Many people stop taking cholesterol-lowering statins because they experience muscle aches, weakness, and fatigue.

AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

Mapping how Narcan reverses opioid overdose can provide a molecular blueprint for developing more effective drugs against overdose.

The Trump administration has lined up another country-specific trade agreement, this time with the U.K., which confers Washington’s biggest break on pharmaceutical import tariffs yet. For its part, ...

Reviva Pharmaceuticals Inc. (NASDAQ: RVPH), a late clinical stage pharmaceutical company aiming to revolutionize the schizophrenia treatment market with Brilaroxazine, its developmental drug, made ...